268 related articles for article (PubMed ID: 23388361)
1. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
5. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
[TBL] [Abstract][Full Text] [Related]
6. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Young JL; Liss MA; Szabo RJ
Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
[TBL] [Abstract][Full Text] [Related]
7. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
[TBL] [Abstract][Full Text] [Related]
8. Clinical and microbiological determinants of infection after transrectal prostate biopsy.
Liss MA; Johnson JR; Porter SB; Johnston B; Clabots C; Gillis K; Nseyo U; Holden M; Sakamoto K; Fierer J
Clin Infect Dis; 2015 Apr; 60(7):979-87. PubMed ID: 25516194
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone-resistant Escherichia coli in the long-term care setting.
Cohen AE; Lautenbach E; Morales KH; Linkin DR
Am J Med; 2006 Nov; 119(11):958-63. PubMed ID: 17071164
[TBL] [Abstract][Full Text] [Related]
10. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
[TBL] [Abstract][Full Text] [Related]
11. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
[TBL] [Abstract][Full Text] [Related]
12. Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon.
Otrock ZK; Oghlakian GO; Salamoun MM; Haddad M; Bizri AR
Infect Control Hosp Epidemiol; 2004 Oct; 25(10):873-7. PubMed ID: 15518032
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study.
Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
J Antimicrob Chemother; 2015 May; 70(5):1547-51. PubMed ID: 25630645
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
Killgore KM; March KL; Guglielmo BJ
Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
